tiprankstipranks
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
US Market
IKT
Inhibikase Therapeutics
RESEARCH TOOLSreports

Inhibikase Therapeutics (IKT) Cash flow

376 Followers

Inhibikase Therapeutics Cash Flow

IKT's free cash flow for Q4 2025 was $-7.97M. For the 2025 fiscal year, IKT's free cash flow was decreased by $-8.64M and operating cash flow was $-7.52M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Mar 23Mar 22
Operating Cash Flow
$ -27.79M$ -19.15M$ -18.09M$ -17.35M$ -14.30M
Investing Cash Flow
$ 2.05M$ -37.00M$ 11.66M$ -16.01M$ 0.00
Financing Cash Flow
$ 108.46M$ 103.48M$ 8.41M$ -204.77K$ 41.09M
End Cash Position
$ 139.22M$ 56.49M$ 9.17M$ 7.19M$ 40.75M
Free Cash Flow
$ -27.79M$ -19.15M$ -18.10M$ -17.59M$ -14.30M
Currency in USD

Inhibikase Therapeutics Cash Flow